Glaucoma, hydrocephalus, and brain edema (cranial fluid volume abnormalities) atriopeptin, guanylate cyclase activator for the treatment, and phosphodiesterase inhibitors

摘要

Method of treating cranial fluid volume dysfunctions such as edema, hydrocephalus, or glaucoma in an individual comprising administering compounds which effect an increase in cyclic GMP at the site of the dysfunction or at the site of synthesis or removal of the accumulating fluid.